Sanatorio Parque
About Sanatorio Parque
"Somos el sanatorio polivalente más avanzado de la región."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Eli Lilly and Company
5
Boehringer Ingelheim
4
Merck Sharp & Dohme LLC
3
Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
2
EMD Serono Research & Development Institute, Inc.
2
Helsinn Healthcare SA
2
Janssen Research & Development, LLC
2
United Therapeutics
2
Argentinian Intensive Care Society
1
Bayer
1
Clinical Trials at Sanatorio Parque
During the past decade, Sanatorio Parque conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 16 clinical trials were completed, i.e. on
average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
2005-12-01
2006-12-01
Terminated
600
Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
2006-01-01
2011-07-01
Completed
721
Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation
2008-01-01
2011-08-01
Unknown status
1,600
Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
2008-04-30
2010-10-19
Completed
390
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
2010-06-22
2018-07-06
Completed
508
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sanatorio Parque" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Eli Lilly and Company" with 5 trials
sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)"
with 3 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Parque"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator and "Canadian VIGOUR Centre" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at Sanatorio Parque
According to Clinical.Site data, the most researched conditions in "Sanatorio Parque" are
"Pulmonary Arterial Hypertension" (4 trials), "Metastatic Breast Cancer" (3 trials), "Prostatic Neoplasms" (3 trials), "Breast Neoplasms" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Sanatorio Parque" in a lesser frequency.
Clinical Trials Intervention Types at Sanatorio Parque
Most popular intervention types in "Sanatorio Parque" are "Drug" (43 trials), "Biological" (8 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Prednisone" (5 trials), "Abemaciclib" (3 trials), "Atezolizumab" (3 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Sanatorio Parque
The vast majority of trials in "Sanatorio Parque" are
41 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.
Clinical Trials Status at Sanatorio Parque
Currently, there are NaN active trials in "Sanatorio Parque".
undefined are not yet recruiting,
6 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 24 completed trials in Sanatorio Parque,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Sanatorio Parque, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 38 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".